VDJ010

(1) To evaluate the safety and tolerability of VDJ010 for subcutaneous injection in single-dose and single- or multiple-dose administration in healthy subjects and patients with ulcerative colitis. (2) To evaluate the pharmacokinetic characteristics of VDJ010 for subcutaneous injection in single-dose and single- or multiple-dose administration in healthy subjects and patients with ulcerative colitis. (3) To evaluate the immunogenicity of VDJ010 for subcutaneous injection in single-dose and single- or multiple-dose administration in healthy subjects and patients with ulcerative colitis. (4) To evaluate the pharmacodynamics of VDJ010 for subcutaneous injection in single-dose and single- or multiple-dose administration in healthy subjects and patients with ulcerative colitis.